IFRX
InflaRx NV
NASDAQ · Healthcare · Biotechnology · DE
$1.45
+9.85%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-26.8%
Return on equity
-23.5%
Return on assets
-24.9%
Return on invested capital
-0.00x
Asset turnover
-$26.7M
Cash from operations
$1.21
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026